Endocrine News and Research

RSS

Pretreatment smoking linked to poor prognosis in AI-treated patients

Among older aromatase inhibitor (AI)-treated patients with breast cancer, current smokers at treatment initiation have an increased risk of breast cancer events and distant metastases, say Swedish researchers.

23 Jun 2016

Apixaban effective in polypharmacy setting

The superiority of apixaban over warfarin in patients with atrial fibrillation is maintained in those taking multiple medications, shows further analysis of the ARISTOTLE trial.

21 Jun 2016

IOF urges clinicians in Asia to prepare for escalating crisis of osteoporosis among elderly people

The International Osteoporosis Foundation is calling on doctors in the Asia-Pacific region to prepare for an immense rise in the number of elderly people suffering broken bones as a result of osteoporosis.

20 Jun 2016

Elevated levels of CXCL10 protein could help diagnose cGvHD in blood, bone marrow transplant patients

A new study published today in the journal Blood has identified a protein that could diagnose chronic graft-versus-host disease (cGvHD), a serious, long-term complication that affects some patients after a blood and bone marrow transplant.

17 Jun 2016

CHLA study provides novel insights into the brain mechanisms linked to Prader-Willi syndrome

A study published in the journal Human Molecular Genetics by researchers at Children's Hospital Los Angeles provides novel insights into the brain mechanisms underlying the insatiable hunger and subsequent obesity in patients with Prader-Willi syndrome.

15 Jun 2016

Endocrine Society members advocate science-based policies to address danger of EDCs

To protect human health, Endocrine Society members called on the European Commission to adopt science-based policies for regulating endocrine-disrupting chemicals in an opinion piece published today in The Lancet Diabetes & Endocrinology.

14 Jun 2016

Molecular imaging technique could help optimize radiotherapy dose to combat NETs

Aggressive neuroendocrine cancer is something of a dark horse--a rare, elusive and persevering force linked to discouraging long-term survival rates.

14 Jun 2016

Genetic blood test can help predict patient’s respone to neuroendocrine cancer therapy

Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, an investigative blood test could predict how patients will respond to peptide receptor radionuclide therapy (PRRT) before they commit to a course of treatment.

14 Jun 2016

Advanced imaging kit Netspot gets FDA approval to detect rare neuroendocrine tumors

The U.S. Food and Drug Administration today approved Netspot, the first kit for the preparation of gallium Ga 68 dotatate injection, a radioactive diagnostic agent for positron emission tomography (PET) imaging.

2 Jun 2016

Scientists reveal how ER+ breast cancer uses cholesterol-based molecule to evade anti-hormone treatments

New research funded by Breast Cancer Now has identified how the most common breast cancers could be using a cholesterol-based molecule to evade standard anti-hormone treatments, causing patients’ disease to return.

2 Jun 2016

Spexin harmone may play role in weight gain among teenagers

A Mayo Clinic-led study found that obese teenagers have lower levels of a hormone potentially tied to weight management than teens of normal weights. The study is published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

27 May 2016

Researchers find potential link between pulmonary function and vocal fatigue symptoms in women

Teaching is an occupation with a high risk of developing vocal problems -- teachers have more than twice the voice problems than people in other professions, as the voice is the major tool in classroom instruction and is often used for long periods of time and in noisy environments.

26 May 2016

Obese teenagers may have lower levels of spexin harmone

Obese teenagers already show signs of hormonal differences from normal-weight peers that may make them prone to weight gain, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

25 May 2016

Antimicrobial agent triclosan can rapidly disrupt gut bacterial communities

A new study suggests that triclosan, an antimicrobial and antifungal agent found in many consumer products ranging from hand soaps to toys and even toothpaste, can rapidly disrupt bacterial communities found in the gut.

24 May 2016

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

The investigational anticancer therapeutic abemaciclib, which targets CDK4 and CDK6, showed durable clinical activity when given as continuous single-agent therapy to patients with a variety of cancer types, including breast cancer, non-small cell lung cancer (NSCLC), glioblastoma, and melanoma, according to results from a phase I clinical trial.

23 May 2016

Study examines effects of ultra-low doses of glyphosate on gene expression profiles

Glyphosate, often sold under the brand name of Roundup, is the world's most widely used weed-killer. While Glyphosate has approval from regulatory bodies worldwide, there are growing concerns about its possible adverse health effects.

20 May 2016

Tecentriq drug gets FDA approval to treat urothelial carcinoma

The U.S. Food and Drug Administration today approved Tecentriq (atezolizumab) to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product in its class (PD-1/PD-L1 inhibitors) approved to treat this type of cancer.

19 May 2016

Biovica acquires cSens AB - creating opportunities for solving cancer diagnostic challenges

Biovica has acquired cSens AB, a company that has developed a PCR-based platform for the analysis of serum thymidine kinase (TK) enzyme activity, which correspond to tumor proliferation and cancer aggressiveness.

18 May 2016

Ipsen partners with IMCB to advance understanding and research of Botulinum Neurotoxin Biology

Ipsen S.A., a global specialty-driven pharmaceutical company, and the Institute of Molecular and Cell Biology (IMCB), a research institute under the aegis of the Agency for Science, Technology and Research (A*STAR), Singapore, today announced the signature of a research partnership to study the intracellular trafficking of botulinum neurotoxins (BoNTs) within neurons.

16 May 2016

Experts review advantages and disadvantages of diagnostic techniques to treat endocrine disorders

Revolutionary changes in medical imaging have enormously improved the ability to detect structural and functional organ alterations early.

11 May 2016

Endocrine News and Research

Pretreatment smoking linked to poor prognosis in AI-treated patients

Apixaban effective in polypharmacy setting

IOF urges clinicians in Asia to prepare for escalating crisis of osteoporosis among elderly people

Elevated levels of CXCL10 protein could help diagnose cGvHD in blood, bone marrow transplant patients

CHLA study provides novel insights into the brain mechanisms linked to Prader-Willi syndrome

Endocrine Society members advocate science-based policies to address danger of EDCs

Molecular imaging technique could help optimize radiotherapy dose to combat NETs

Genetic blood test can help predict patient’s respone to neuroendocrine cancer therapy

Advanced imaging kit Netspot gets FDA approval to detect rare neuroendocrine tumors

Scientists reveal how ER+ breast cancer uses cholesterol-based molecule to evade anti-hormone treatments

Spexin harmone may play role in weight gain among teenagers

Researchers find potential link between pulmonary function and vocal fatigue symptoms in women

Obese teenagers may have lower levels of spexin harmone

Antimicrobial agent triclosan can rapidly disrupt gut bacterial communities

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

Study examines effects of ultra-low doses of glyphosate on gene expression profiles

Tecentriq drug gets FDA approval to treat urothelial carcinoma

Biovica acquires cSens AB - creating opportunities for solving cancer diagnostic challenges

Ipsen partners with IMCB to advance understanding and research of Botulinum Neurotoxin Biology

Experts review advantages and disadvantages of diagnostic techniques to treat endocrine disorders

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News